# Correction to: Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer

PMC · DOI: 10.1093/stcltm/szaf021 · Stem Cells Translational Medicine · 2025-05-26

## Full-text entities

- **Diseases:** Metastatic (MESH:D000092182), Lung Cancer (MESH:D008175)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12105609/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12105609/full.md

---
Source: https://tomesphere.com/paper/PMC12105609